DHI
DR Horton Inc
DR Horton Inc historical holders
total: 14
Berkshire Hathaway DR Horton Inc transactions over time
- Total transactions:
- 6
- New positions:
- 3
- Sold out:
- 2
- Reduced:
- 1
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
Warren Buffett has been an institutional investor in DR Horton Inc (DHI) since 2023 Q2. According to 2026 Q2 report, Warren Buffett holds 3,564 shares with a market value of roughly $580.50K representing 0.00% of their equity portfolio. The fund/company first acquired DHI in 2023 Q2, initially purchasing about 5.97M shares. Warren Buffett later completely sold out the position and reinvested in DHI again in 2026 Q2. Since the initial investment, Berkshire Hathaway has made 5 more transactions in this position.
Does Warren Buffett still hold DHI?
Yes, Warren Buffett continues to hold DR Horton Inc (DHI). According to their 2026 Q2 report, they maintain a position of 3,564 shares valued at approximately $580.50K, representing 0.00% of their equity portfolio.
When did Warren Buffett first invest in DHI?
Warren Buffett first invested in DR Horton Inc (DHI) in 2023 Q2 at the reported quarter-end price of $121.69 per share, acquiring 5,969,714 shares in their initial purchase.
What is Warren Buffett's average cost basis for DHI?
Based on historical transaction data, Warren Buffett's estimated cost basis for DR Horton Inc (DHI) is approximately $162.88 per share. This represents their average reported price* across all buy transactions.
Has Warren Buffett reinvested in DHI after selling?
Yes, Warren Buffett has shown renewed interest in DR Horton Inc (DHI). After completely selling their position, they reinitiated an investment in 2026 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $162.88
DHI transactions history by Berkshire Hathaway
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
3,564
|
$162.88
|
$580,504
|
new
|
+0%
|
|
2025 Q3
|
0.00%
|
0
|
$128.92
|
|
-100% (-1,485,350)
|
-0.07%
|
|
2025 Q2
|
0.07%
|
1,485,350
|
$128.92
|
$191,491,322
|
-1.79% (-27,021)
|
-0%
|
|
2025 Q1
|
0.07%
|
1,512,371
|
$127.13
|
$192,267,725
|
new
|
+0.07%
|
|
2023 Q4
|
0.00%
|
0
|
$107.47
|
|
-100% (-5,969,714)
|
-0.2%
|
|
2023 Q2
|
0.21%
|
5,969,714
|
$121.69
|
$726,454,496
|
new
|
+0.21%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.